logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nan Zhang

Peking Union Medical College Hospital
H指数:32
被引数:4,088

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spatiotemporal landscape of intrahepatic cholangiocarcinoma liver metastasis at the single-cell level

肝内胆管癌肝脏转移在单细胞水平的时空景观

HEPATOLOGY
IF15.8
2025-12-010
PRE
Xun, Ziyu; Wang, Hao; Xuan, Zhengfeng; Xiong, Kexu; Zhang, Nan; Long, Junyu; Sun, Huishan; Li, Yiran; Zhu, Chengpei; Piao, Mingjian; Zhang, Ting; Zhang, Longhao; Li, Shuofeng; Li, Chengjie; Li, Jiongyuan; Sun, Boyu; Zhou, Zixiang; Wang, Shanshan; Huang, Ziyue; Liu, Kai; Tan, Yang; Shi, Xiaohua; Yang, Xiaobo; Wang, Hanping; Lu, Ling; Zhao, Haitao
Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+fibroblasts and ACKR1+endothelial cells in immune-related myocarditis

单细胞转录组分析揭示了以CXCL9^+成纤维细胞和ACKR1^+内皮细胞为特征的炎症微环境在免疫相关心肌炎中的作用。

JOURNAL OF TRANSLATIONAL MEDICINE
IF7.5
2025-05-160
OA
Sun, Boyu; Xun, Ziyu; Zhou, Zixiang; Zhang, Nan; Piao, Mingjian; Li, Chengjie; Li, Jiongyuan; Li, Shuofeng; Zhang, Longhao; Chen, Xiangqi; Wang, Hanping
Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer (vol 73, 240, 2024)

仑伐替尼联合抗PD-1抗体以及GEMOX化疗作为晚期胆囊癌非一线全身治疗的疗效与安全性（卷73，240，2024）

CANCER IMMUNOLOGY IMMUNOTHERAPY
IF5.1
2025-04-210
OA
Tan, Yang; Liu, Kai; Zhu, Chengpei; Wang, Shanshan; Wang, Yunchao; Xue, Jingnan; Ning, Cong; Zhang, Nan; Chao, Jiashuo; Zhang, Longhao; Long, Junyu; Yang, Xiaobo; Zeng, Daobing; Zhao, Lijin; Zhao, Haitao

研究方向

暂未获取到该数据
H
Haitao Zhao
H 指数:58论文数:555被引数:1.4万
Z
Ziyu Xun
H 指数:15论文数:90被引数:942
L
Longhao Zhang
H 指数:22论文数:113被引数:1,453
J
Jingnan Xue
H 指数:11论文数:62被引数:631
X
Xiaobo Yang
H 指数:38论文数:142被引数:4,446
C
Chengpei Zhu
H 指数:20论文数:59被引数:1,080
J
Junyu Long
H 指数:34论文数:141被引数:3,764
王云超 封面图
王云超
H 指数:20论文数:118被引数:1,398
X
Xinting Sang
H 指数:44论文数:326被引数:6,755
M
Mingjian Piao
H 指数:6论文数:27被引数:323